BIOMARKERS FOR EARLY TREATMENT RESPONSE TO BIOLOGICS IN TREATMENT OF RHEUMATOID ARTHRITIS.

被引：0
|
作者：
Zhang, Lijun [1 ]
Zhang, Li [2 ]
Amur, Shashi [2 ]
Siegel, Jeff [3 ]
Ding, Xiao [4 ]
Lau, Olivia [4 ]
Rochester, George [4 ]
Tornoe, Christoffer W. [5 ]
Doddapaneni, Suresh [1 ]
Sahajwalla, Chandrahas [1 ]
Nallani, Srikanth C. [1 ]
机构：
[1] Div Clin Pharmacol, Silver Spring, MD USA
[2] Genom Grp, Silver Spring, MD USA
[3] Div Anesthesia Analgesia & Rheumatol Prod, Silver Spring, MD USA
[4] Off Biostatist, Silver Spring, MD USA
[5] Food & Drug Adm, CDER, Div Pharmacometr, Silver Spring, MD USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
114
引用
收藏
页码：1083 / 1083
页数：1
相关论文
共 50 条
  • [21] Deoxycoformycin (pentostatin) for the treatment of rheumatoid arthritis.
    Albert, DA
    MacDonald, P
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A330 - A330
  • [22] GCS IN THE TREATMENT OF RHEUMATOID ARTHRITIS. FRIENDS ?
    Messina, O. D.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S95 - S95
  • [23] TREATMENT OF RHEUMATOID ARTHRITIS - COMPARATIVE EFFECTIVENESS OF BIOLOGICS
    Schiffner-Rohe, J.
    Leverkus, F.
    Behmer, O. S.
    Kerkmann, U.
    VALUE IN HEALTH, 2012, 15 (07) : A461 - A461
  • [24] Age At Onset Determines Severity and choice of Treatment in Early Rheumatoid Arthritis.
    Innala, Lena
    Moller, Bozena
    Ljung, Lotta
    Smedby, Torgny
    Sodergren, Anna
    Magnusson, Staffan
    Berglin, Ewa H.
    Rantapaa-Dahlqvist, Solbritt M.
    Wallberg-Jonsson, Solveig
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S908 - S908
  • [25] Cost effectiveness of biologics in the treatment of rheumatoid arthritis
    Müller-Ladner, U
    INTERNIST, 2004, 45 (12): : 1402 - 1406
  • [26] The Role of Biologics in The Treatment of Rheumatoid Arthritis: A Review
    Bookya, Kishan
    Balaji, Bairam
    Kathyayani, R.
    Mangilal, Teelavath
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2015, 4 (04): : 1 - 8
  • [27] Factors Influencing Implementation of Intensive Treatment Strategies for Early Rheumatoid Arthritis.
    Meyfroidt, Sabrina
    De Cock, Diederik
    Van der Elst, Kristien
    van Hulst, Laura
    Hulscher, Marlies
    Joly, Johan
    Westhovens, Rene
    Verschueren, Patrick
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S668 - S668
  • [28] THE FUTURE OF BIOLOGICS IN THE TREATMENT OF RHEUMATOID-ARTHRITIS
    KOOPMAN, WJ
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1994, 23 (06) : 50 - 58
  • [29] Cost effectiveness of five biologics in the treatment of long-standing moderate to severe rheumatoid arthritis.
    Davies, A.
    Segurado, O. G.
    Cifaldi, M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S336 - S337
  • [30] The use of biologics in the treatment of rheumatoid arthritis (RA)
    Manolios, N
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1997, 27 (05): : 607 - 607
12345